Company / Named in our posts
OS Therapies.
Follow OS TherapiesOS Therapies is a clinical-stage oncology company focused on identifying, developing, and commercializing immunotherapy candidates for solid tumors, beginning with osteosarcoma.[1]
01Deal
Deals on Carrywatch
Every deal that names OS Therapies, and its role in each.
OS Therapies / Ayala Pharmaceuticals
OS Therapies completes immunotherapy asset acquisition
See deal detailsDeal Web
OS Therapies and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
2 fiscal years of figures as OS Therapies reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals
Company disclosure · Researched 25 Oct 2026
- 02SEC EDGAR company record for OS Therapies Inc (CIK 0001795091)
Company disclosure · Researched 25 Oct 2026
Deal posts naming OS Therapies:
- P01